Aimia stock gains 0.39 percent and joins London's AIM

Published on 10/08/2026 at 07:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aimia stock was last at CAD 2.60 on October 7, 2026, while its 52-week high was CAD 3.44. MarketBeat lists a CAD 3.38 average target.

AJA, CA00900Q1037, Illustration mit AI erstellt.

Aimia Inc. (ISIN CA00900Q1037) was last at CAD 2.60 on the Toronto Stock Exchange on October 7, 2026, at 3:59 p.m. ET, up 0.39 percent from the prior close. The latest company event is its new London market access, with trading on the AIM market starting October 1, 2026, under ticker AII, as Yahoo Finance reported.

London listing broadens access

The AIM admission adds a London quotation to Aimia's existing Toronto and Johannesburg listings. The company said its common shares would begin dealings at 8:00 a.m. BST on October 1, 2026, with AII as the London ticker and CA00900Q1037 as the ISIN, according to Yahoo Finance.

The new quotation comes after Aimia positioned itself as a diversified holding company focused on increasing the value of its investments, reducing corporate costs, and redeploying capital into undervalued companies. That structure makes the London listing relevant mainly as an access and visibility event rather than as a new operating segment.

Consensus target stays above price

MarketBeat lists a Moderate Buy consensus for Aimia, based on two analysts, with a CAD 3.38 average target, a CAD 3.00 low target, and a CAD 3.75 high target. At CAD 2.60, the average target lies 30.0 percent above the October 7 price, according to MarketBeat.

The latest reported quarter was Q2 2026, ended June 30, 2026. MarketBeat recorded quarterly EPS of CAD 0.11 and revenue of CAD 36.40 million in its Aimia results summary, while the company had reported those figures on August 11, 2026, according to MarketBeat.

Stock remains below yearly high

Aimia's October 7 market capitalization was CAD 229.8 million, with 45,400 shares traded. The 52-week range was CAD 2.48 to CAD 3.44, placing the last price 24.4 percent below the yearly high and CAD 0.12 above the yearly low.

The price and the London admission now frame the stock's near-term story: expanded market access on one side, and a small-cap valuation still below the top of its annual range on the other.